Table 5 Articles that analysed more than one African country
From: Bibliometric trends of health economic evaluation in Sub-Saharan Africa
Countries included in the study | Title of the Article | Year |
|---|---|---|
Botswana/Kenya/South Africa/Tanzania | Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation | 2010 |
Botswana/Kenya/Tanzania/Uganda/Zambia/Zimbabwe. | Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries | 2004 |
Kenya/Mozambique/Tanzania/Uganda/Zimbabwe | Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa | 2012 |
Kenya/Uganda | Economics of switching to second-line antiretroviral therapy with Lopinavir/ritonavir in Africa: estimates based on DART trial results and costs for Uganda and Kenya | 2011 |
Malawi/Mozambique | Predicting trends in HIV-1 sexual transmission in sub-Saharan Africa through the drug resource enhancement against AIDS and malnutrition model: antiretroviral for reduction of population infectivity, incidence and prevalence at the district level. | 2012 |
Malawi/South Africa/Zimbabwe | Cost-effective diagnostic checklists for meningitis in resource-limited settings | 2013 |
Mozambique/Tanzania | Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania | 2009 |
Nigeria/Ghana | Cost-effectiveness analysis of unsafe abortion and alternative first-trimester pregnancy termination strategies in Nigeria and Ghana | 2010 |
Nigeria/South Africa | The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa | 2013 |
South Africa/Malawi | Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011–2050 | 2012 |
Swaziland/Lesotho/Botswana/Malawi/Mozambique/Namibia/South Africa/Tanzania/Uganda/Zambia/Zimbabwe/Kenya | Voluntary medical male circumcision: modelling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa | 2012 |
Swaziland/Tanzania/Uganda/Zambia | Assessing effectiveness and cost-effectiveness of concurrency reduction for HIV prevention | 2011 |
Zimbabwe/Uganda | Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe | 2012 |